Axogen, Inc. Payments to Acquire Investments
Axogen, Inc. (AXGN) reported Payments to Acquire Investments of $18.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-07-29
- Axogen, Inc. payments to acquire investments for the quarter ending 2026-06-30 was -$250.00K, a 103.19% decline year-over-year.
- Axogen, Inc. payments to acquire investments for the quarter ending 2026-03-31 was $19.00M.
- Axogen, Inc. payments to acquire investments for the quarter ending 2025-12-31 was $0.00.
- Axogen, Inc. payments to acquire investments for the quarter ending 2025-09-30 was $5.89M, a 52.41% increase year-over-year.
- Axogen, Inc. payments to acquire investments for fiscal 2025 was $13.72M, a 137.71% increase from fiscal 2024.
- Axogen, Inc. payments to acquire investments for fiscal 2024 was $5.77M, a 43.42% decline from fiscal 2023.
- Axogen, Inc. payments to acquire investments for fiscal 2023 was $10.20M, a 74.00% decline from fiscal 2022.
- Axogen, Inc. payments to acquire investments for fiscal 2022 was $39.25M, a 42.87% decline from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $18.75M 10-Q · filed 2026-07-29 | $18.75M derived: sum of 3 quarters · filed 2026-07-29 | $24.64M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $19.00M 10-Q · filed 2026-04-28 | $19.00M derived: sum of 2 quarters · filed 2026-04-28 | $24.89M derived: sum of 3 quarters · filed 2026-04-28 | $32.72M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.89M derived: sum of 2 quarters · filed 2026-02-24 | $13.72M derived: sum of 3 quarters · filed 2026-07-29 | $13.72M 10-K · filed 2026-02-24 |
| 2025-09-30 | $5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $13.72M derived: sum of 2 quarters · filed 2026-07-29 | $13.72M 10-Q · filed 2025-10-29 | $13.72M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $7.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $7.84M 10-Q · filed 2026-07-29 | $7.84M derived: sum of 3 quarters · filed 2026-07-29 | $11.70M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-28 | $0.00 derived: sum of 2 quarters · filed 2026-04-28 | $3.86M derived: sum of 3 quarters · filed 2026-04-28 | $3.86M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.86M derived: sum of 2 quarters · filed 2026-02-24 | $3.86M derived: sum of 3 quarters · filed 2026-02-24 | $5.77M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.86M derived: sum of 2 quarters · filed 2025-10-29 | $5.77M 10-Q · filed 2025-10-29 | $5.77M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.91M 10-Q · filed 2025-08-05 | $1.91M derived: sum of 3 quarters · filed 2026-02-24 | $1.91M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.91M 10-Q · filed 2025-05-08 | $1.91M derived: sum of 2 quarters · filed 2026-02-24 | $1.91M derived: sum of 3 quarters · filed 2026-02-24 | $1.91M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $10.20M 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $10.20M 10-Q · filed 2024-11-07 | $24.84M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $10.20M 10-Q · filed 2024-08-08 | $24.84M derived: sum of 3 quarters · filed 2025-02-26 | $43.43M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $10.20M 10-Q · filed 2024-05-02 | $24.84M derived: sum of 2 quarters · filed 2025-02-26 | $43.43M derived: sum of 3 quarters · filed 2025-02-26 | $43.43M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $14.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $33.22M derived: sum of 2 quarters · filed 2025-02-26 | $33.22M derived: sum of 3 quarters · filed 2025-02-26 | $39.25M 10-K · filed 2025-02-26 |
| 2022-09-30 | $18.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $18.58M derived: sum of 2 quarters · filed 2023-11-07 | $24.61M 10-Q · filed 2023-11-07 | $54.17M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $6.02M 10-Q · filed 2023-08-08 | $35.58M derived: sum of 3 quarters · filed 2024-03-05 | $50.76M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $6.02M 10-Q · filed 2023-05-09 | $35.58M derived: sum of 2 quarters · filed 2024-03-05 | $50.76M derived: sum of 3 quarters · filed 2024-03-05 | $59.44M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $29.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $44.73M derived: sum of 2 quarters · filed 2024-03-05 | $53.42M derived: sum of 3 quarters · filed 2024-03-05 | $68.70M 10-K · filed 2024-03-05 |
| 2021-09-30 | $15.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $23.86M derived: sum of 2 quarters · filed 2022-11-08 | $39.14M 10-Q · filed 2022-11-08 | $75.15M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | $8.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $23.97M 10-Q · filed 2022-08-05 | $59.98M derived: sum of 3 quarters · filed 2023-03-14 | $78.81M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | $15.28M 10-Q · filed 2022-05-05 | $51.29M derived: sum of 2 quarters · filed 2023-03-14 | $70.12M derived: sum of 3 quarters · filed 2023-03-14 | $81.33M derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | $36.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $54.84M derived: sum of 2 quarters · filed 2023-03-14 | $66.05M derived: sum of 3 quarters · filed 2023-03-14 | $77.81M 10-K · filed 2023-03-14 |
| 2020-09-30 | $18.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $30.03M derived: sum of 2 quarters · filed 2021-11-04 | $41.79M 10-Q · filed 2021-11-04 | $58.55M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $22.96M 10-Q · filed 2021-08-05 | $39.73M derived: sum of 3 quarters · filed 2022-02-25 | $59.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $11.76M 10-Q · filed 2021-05-06 | $28.52M derived: sum of 2 quarters · filed 2022-02-25 | $48.69M derived: sum of 3 quarters · filed 2022-02-25 | $83.92M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $16.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $36.93M derived: sum of 2 quarters · filed 2022-02-25 | $72.16M derived: sum of 3 quarters · filed 2022-02-25 | $121.07M 10-K · filed 2022-02-25 |
| 2019-09-30 | $20.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $55.40M derived: sum of 2 quarters · filed 2020-10-30 | $104.31M 10-Q · filed 2020-10-30 | $115.19M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $35.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $84.14M 10-Q · filed 2020-08-07 | $95.01M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $48.91M 10-Q · filed 2020-05-06 | $59.78M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $10.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $114.74M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $103.86M 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |